Contextual Interference, Engagement , & Change in Motor Performance in

Status Recruiting

Clinical Trial Summary

The aim of the study is to examine associations between contextual interference (CI), engagement during practice and changes in upper limb motor performance among patients post-stroke. Fifty patients over the age of 18, after a stroke, in the sub-acute and early chronic stages who have weakness of the upper extremity and are treated in a rehabilitation center will be recruited. The study will include participation in five sessions: session 1 for baseline assessment, session 2-4 for practice of upper extremity functions, and session 5 for post intervention assessment. The intervention will include training of three items from the Wolf motor function test in random order (high CI group) or block order (low CI group). Outcomes of engagement will include the brain engagement index, heart rate variability and galvanic skin response. Outcomes of learning will include the pre-post change in performance of the wolf motor function selected items.

Clinical Trial Description

The aim of the study is to examine associations between contextual interference (CI), engagement during practice, and changes in upper limb motor performance among patients post-stroke. Fifty patients over the age of 18, after a stroke, in the sub-acute and early chronic stages who are treated in a rehabilitation center inpatient or outpatient clinics, who have hemiparesis (Fugl-Meyer score = 11-60) will be recruited. Patients with a history of neurological diseases other than stroke or orthopedics conditions that impair upper extremity function, pain that prevents active movement, hemodynamic instability, cognitive decline and language difficulties that do not allow understanding of instructions and cooperation will be excluded. The study will include participation in five sessions. In the first session, participants will answer a demographic questionnaire and a set of motor (including the Wolf motor function test), perception and cognitive tests will be delivered. Then participants will be assigned to either high or low CI groups. In the next three sessions, participants will practice three items from the Wolf motor functions test. Participants in the high CI group will practice the items in random order and those in the low CI group will practice the selected items in blocked order. Assessment of outcomes during practice will include assessment of brain engagement index by recording EEG (one electrode) and heart rate variability and galvanic skin response. In the fifth session, at the end of the intervention, a reassessment of the wolf motor function performance will be performed. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05342688
Study type	Interventional
Source	University of Haifa
Contact	Michal Kafri, PhD
Phone	972586862261
Email	kafri.michal@gmail.com
Status	Recruiting
Phase	Phase 1
Start date	January 1, 2020
Completion date	June 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04323943` - Comparison of Thermo-plastic Versus Carbon Foot Ankle Orthosis to Improve Gait and Reduce Fatigue in Post-stroke Patients: a Biomechanical and Neurophysiological Study	N/A
Completed	`NCT05062746` - Immediate Effect of One-session MRT in Hemiparetics	N/A
Not yet recruiting	`NCT05626894` - Novel Wrist Sensor System to Promote Hemiparetic Arm Use in Home Daily Life of Chronic Stroke Survivors	Phase 2
Recruiting	`NCT05399121` - Stroke Patients', Music Therapist' Engagement and Patients' Finger Movement During Music Therapeutic Interaction	N/A
Recruiting	`NCT04620707` - RGS@Home: Personalized 24/7 Home Care Post-stroke	N/A
Recruiting	`NCT06230796` - Effects of Functional Electrical Stimulation Assisted Cycling in Patients With Hemiparesis After Stroke	N/A
Recruiting	`NCT05809037` - Evaluation of Noninvasive Vagus Nerve Stimulation on Functional Status in Ischemic Stroke	N/A
Recruiting	`NCT06107010` - Effects of Atalante Exoskeleton on Gait Recovery in Non- or Poorly Ambulatory Patients With Hemiparesis in the Acute/Subacute Phase (Month 1 to 4)	N/A
Terminated	`NCT05011448` - Correlation Between Music Therapist's and Stroke Patient's Engagement Levels and Patient's Fingers and Wrist Movement	N/A
Active, not recruiting	`NCT04309266` - The Impact of Robot Assisted Therapy and Metacognitive Skills Training for Children With Hemiparesis	N/A
Recruiting	`NCT06362954` - The Relationship Between Muscle Oxygenation and Spasticity in Hemiparetic Stroke Patients
Recruiting	`NCT06109194` - Immediate Effect of Ankle Mobilization on Active Range of Motion and Gait in Subacute Stroke	N/A
Recruiting	`NCT06140381` - Strengthening in Sub-acute Stroke Survivors: A Randomized Controlled Trial	N/A
Completed	`NCT04314830` - Gait Perturbations to Improve Balance Post-stroke	N/A
Completed	`NCT05097391` - Effectiveness of Paretic Lower Limb Loading During Over-ground Training Among Stroke Survivors	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Contextual Interference, Engagement , and Change in Motor Performance in Stroke

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms